Clinical Aspects and Management of Levodopa-Induced Dyskinesia
In Parkinson's disease, one of the most troublesome dilemmas is the treatment of levodopa-induced dyskinesia. After a few years, chronic treatment with levodopa is associated with the development of dyskinesias. Strategies to delay or to reduce dyskinesias are based on the change of levodopa do...
Saved in:
Main Authors: | Nicola Tambasco, Simone Simoni, Erica Marsili, Elisa Sacchini, Donatella Murasecco, Gabriela Cardaioli, Aroldo Rossi, Paolo Calabresi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2012/745947 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease
by: J. Guridi, et al.
Published: (2012-01-01) -
Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia
by: Veronica Ghiglieri, et al.
Published: (2012-01-01) -
Understanding and Prevention of “Therapy-” Induced Dyskinesias
by: Iciar Aviles-Olmos, et al.
Published: (2012-01-01) -
Dyskinesia in Parkinson's Disease Therapy
by: Anna Rosa Carta, et al.
Published: (2012-01-01) -
Paroxysmal Nonkinesigenic Dyskinesia with Tremor
by: Robert Fekete
Published: (2013-01-01)